K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar

BACKGROUND: Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Myanmar-Thailand border raise concerns over resist...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Malar J
Huvudupphovsmän: Win, Aye A., Imwong, Mallika, Kyaw, Myat P., Woodrow, Charles J., Chotivanich, Kesinee, Hanboonkunupakarn, Borimas, Pukrittayakamee, Sasithon
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4765153/
https://ncbi.nlm.nih.gov/pubmed/26911145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-016-1147-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk